Your doctor will diagnose you based on your symptoms, medical history, physical exam, and cognitive tests
Everything here is research-use-only and not for human consumption
Enhanced binding to human serum albumin, together with increased molecular size, likely contributes to reduced clearance and extended exposure
Hepatology (2018)
The ideal candidate for either drug is someone who: Has clinically significant excess weight with metabolic consequences Has tried lifestyle modification (diet, exercise) with insufficient results Wants to meaningfully reduce cardiovascular, metabolic, or all-cause mortality risk Is prepared to commit to the ongoing nature of the treatment Is not pregnant, and does not have a personal or family history of medullary thyroid carcinoma or MEN2 If you're leaning toward tirzepatide specifically, it makes sense if maximizing weight loss is the primary goal, you have significant insulin resistance or type 2 diabetes, and you want the most aggressive metabolic improvement available right now
Heres a look at whats on the market and whats potentially in the pipeline for 2026
